Results 21 to 30 of about 2,485 (155)

Finally, PrEP choices! But will clients ever have a choice? [PDF]

J Int AIDS Soc
Journal of the International AIDS Society, Volume 28, Issue S2, July 2025.
Kimberly E. Green, Kenneth Ngure, Robyn Eakle, Nittaya Phanuphak, Jason Reed   +4 more
wiley   +2 more sources

PrEP preferences and early acceptability of injectable cabotegravir among pregnant and lactating people in Cape Town, South Africa: findings from the PrEPared to Choose study [PDF]

Journal of the International AIDS Society, Volume 28, Issue S2, July 2025.
Abstract Introduction Providing pregnant and lactating people (PLP) with choice in HIV pre‐exposure prophylaxis (PrEP) methods, including long‐acting injectable cabotegravir (CAB‐LA), may mitigate barriers to effective PrEP use. We evaluated PrEP preferences and acceptability among PLP offered CAB‐LA versus oral PrEP in South Africa.
Nafisa Wara, Carey Pike, Elzette Rousseau, Pippa Macdonald, Pakama Mapukata, Bryan Leonard, Keitumetse Lebelo, Risa Hoffman, Catherine Orrell, Linda‐Gail Bekker, Dvora Joseph Davey   +10 more
wiley   +2 more sources

A mixed-method study of feasibility and acceptability of the Dapivirine vaginal ring among adolescent girls and young women (AGYW) in selected Zimbabwean districts. [PDF]

PLOS Global Public Health
The Dapivirine vaginal ring (DPV-VR) is an intravaginal silicone ring that delivers an antiretroviral drug (Dapivirine) directly to vaginal tissues for 28 days.
Noah Taruberekera, Malvern Munjoma, Owen Mugurungi, Getrude Ncube, Miriam Mutseta, Munyaradzi Dhodho, Hanul Choi, Jabulani Mavudze, Tafara Moga, Blessing Mutede   +9 more
doaj   +2 more sources

Acceptability of a dapivirine levonorgestrel vaginal ring in two Phase 1 trials (MTN-030/IPM 041 and MTN-044/IPM 053/CCN019): Implications for multipurpose prevention technology development. [PDF]

PLoS ONE
End-user feedback early in product development is important for optimizing multipurpose prevention technologies for HIV and pregnancy prevention. We evaluated the acceptability of the 90-day dapivirine levonorgestrel ring (DPV-LNG ring) used for 14 days ...
Barbara A Friedland, Holly Gundacker, Sharon L Achilles, Beatrice A Chen, Craig Hoesley, Barbra A Richardson, Clifton W Kelly, Jeanna Piper, Sherri Johnson, Brid Devlin, John Steytler, Kyle Kleinbeck, Bindi Dangi, Chantél Friend, Mei Song, Barbara Mensch, Ariane van der Straten, Cindy Jacobson, Craig W Hendrix, Jill Brown, Diana Blithe, Sharon L Hiller, MTN-030/IPM 041 and MTN-044/IPM 053/CCN019 Protocol Teams for the Microbicide Trials Network and the Contraceptive Clinical Trials Network   +22 more
doaj   +2 more sources

PrEP and choice counselling – Insights into implementation [PDF]

Journal of Public Health in Africa
Adolescent girls and young women are disproportionately affected by human immunodeficiency virus (HIV). The introduction of oral pre-exposure prophylaxis (PrEP) was a game-changer in HIV prevention.
Melanie Pleaner, Faith Musvipwa, Siphokazi Dada, Fatima A. Cholo, Catherine E. Martin, Alison Kutywayo, Vusile Butler, Saiqa Mullick   +7 more
doaj   +2 more sources

Oral pre-exposure prophylaxis implementation in South Africa: a case study of USAID-supported programs [PDF]

Frontiers in Reproductive Health
Since the introduction of oral pre-exposure prophylaxis (PrEP) in 2016, countries have successfully scaled-up PrEP to populations at risk of HIV acquisition, including key populations, serodiscordant couples and pregnant women.
Jerome Wendoh Milimu, Lauren Parmley, Mahlodi Matjeng, Mathata Madibane, Mandisi Mabika, Jacques Livingston, Joseph Lawrence, Orapeleng Motlhaoleng, Hasina Subedar, Rethabile Tsekoa, Zandile Mthembu   +10 more
doaj   +2 more sources

Self-reported removal and expulsion of the dapivirine vaginal ring: qualitative reports from female ring users and their male partners in the Ring Study (IPM 027) [PDF]

BMC Public Health
Background/aims The dapivirine vaginal ring is a self-administered, women-initiated, discreet, long-acting HIV-1 prevention option for women. It was found to be safe and effective in healthy HIV-negative women who adhered to product use instructions, and
Cecilia Milford, Hariska Ramlal, Rorisang Mofokeng, Letitia Rambally Greener, Annaléne Nel, Jennifer Smit, Mariëtte Malherbe   +6 more
doaj   +2 more sources

Leveraging international stakeholders’ experiences with oral PrEP costs to accelerate implementation of the monthly dapivirine vaginal ring: A qualitative study [PDF]

Health Research Policy and Systems
Background Costing and financing systematic implementation are recognized barriers to human immunodeficiency virus (HIV) prevention. In the absence of empiric implementation and economic data, perspectives from international stakeholders involved in ...
Craig J. Heck, Katharine Kripke, Anita Dam, Sergio Torres-Rueda, Fiammetta Bozzani, Chris Obermeyer, Kibret Yohannes, Justine Deacon, Kathrine Meyers, Daniela Quigee, Sarah Wiant, Steven Forsythe, Christine Malati, Martha Larson, Magdalena E. Sobieszczyk, Delivette Castor   +15 more
doaj   +2 more sources

Estimating the cost of and willingness to pay for providing the dapivirine ring for HIV prevention in Kenya [PDF]

BMC Public Health
Background As Kenya prepared to introduce the PrEP ring (a long-acting product used by women for HIV prevention), the need to understand the resources required became increasingly important.
Peter Stegman, Steven Forsythe, Urbanus Kioko, Millicent Kiruki, Patriciah Jeckonia, Martha Larson, Delivette Castor, Guy Mahiane, Maryline Mireku, Mike Ekisa, Kristine Torjesen, Mary Mugambi, Daniel Were, Katharine Kripke   +13 more
doaj   +2 more sources

HIV prevention at drug shops: awareness and attitudes among shop dispensers and young women about oral pre-exposure prophylaxis and the dapivirine ring in Shinyanga, Tanzania

AIDS Research and Therapy, 2021
Background HIV risk remains high among adolescent girls and young women (AGYW, ages 15–24) in Tanzania. Many AGYW experience stigma and provider bias at health facilities, deterring their use of HIV prevention services.
Julia Tubert, Laura Packel, Lauren A. Hunter, Rashid Mfaume, Prosper Njau, Angela A. Ramadhani, Jenny X. Liu, Sandra I. McCoy   +7 more
doaj   +1 more source